Koji Nakamura - Search Results

Year	Number of Results
2002	6
2003	8
2004	12
2005	8
2006	3
2007	3
2008	3
2009	5
2010	7
2011	5
2012	4
2013	5
2014	5
2015	9
2016	10
2017	8
2018	12
2019	8
2020	5
2021	17
2022	19
2023	7
2024	0

1

A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies.

Manna L, Rapuano Lembo R, Yoshioka A, Nakamura K, Passariello M, De Lorenzo C. Manna L, et al. Among authors: nakamura k. Cancers (Basel). 2023 Nov 9;15(22):5345. doi: 10.3390/cancers15225345. Cancers (Basel). 2023. PMID: 38001604 Free PMC article.

2

Continuous Administration of Anti-VEGFA Antibody Upregulates PAI-1 Secretion from Ovarian Cancer Cells via miR-143-3p Downregulation.

Yagi T, Sawada K, Miyamoto M, Shimizu A, Oi Y, Toda A, Nakamura K, Kinose Y, Kodama M, Hashimoto K, Kimura T. Yagi T, et al. Among authors: nakamura k. Mol Cancer Res. 2023 Oct 2;21(10):1093-1106. doi: 10.1158/1541-7786.MCR-23-0015. Mol Cancer Res. 2023. PMID: 37327051

3

Estrogen induces genomic instability in high-risk HPV-infected cervix and promotes the carcinogenesis of cervical adenocarcinoma.

Ogawa M, Hashimoto K, Kitano S, Yamashita S, Toda A, Nakamura K, Kinose Y, Kodama M, Sawada K, Kimura T. Ogawa M, et al. Among authors: nakamura k. Biochem Biophys Res Commun. 2023 Jun 4;659:80-90. doi: 10.1016/j.bbrc.2023.04.009. Epub 2023 Apr 8. Biochem Biophys Res Commun. 2023. PMID: 37054506

4

Investigating the diversity of bioluminescent marine worm Polycirrus (Annelida), with description of three new species from the Western Pacific.

Jimi N, Bessho-Uehara M, Nakamura K, Sakata M, Hayashi T, Kanie S, Mitani Y, Ohmiya Y, Tsuyuki A, Ota Y, Woo SP, Ogoh K. Jimi N, et al. Among authors: nakamura k. R Soc Open Sci. 2023 Mar 29;10(3):230039. doi: 10.1098/rsos.230039. eCollection 2023 Mar. R Soc Open Sci. 2023. PMID: 36998762 Free PMC article.

5

Prospective study of three saliva qualitative antigen testing kits for the detection of SARS-CoV-2 among mainly symptomatic patients in Japan.

Terada N, Akashi Y, Takeuchi Y, Ueda A, Notake S, Nakamura K, Suzuki H. Terada N, et al. Among authors: nakamura k. J Infect Chemother. 2023 Jul;29(7):654-659. doi: 10.1016/j.jiac.2023.03.005. Epub 2023 Mar 7. J Infect Chemother. 2023. PMID: 36894015 Free PMC article.

6

Development of a novel Poly (I:C)-induced murine model with accelerated lupus nephritis and examination of the therapeutic effects of mycophenolate mofetil and a cathepsin S inhibitor.

Kawato Y, Fukahori H, Nakamura K, Kubo K, Hiramitsu M, Kinugasa F, Morokata T. Kawato Y, et al. Among authors: nakamura k. Eur J Pharmacol. 2023 Jan 5;938:175440. doi: 10.1016/j.ejphar.2022.175440. Epub 2022 Dec 1. Eur J Pharmacol. 2023. PMID: 36463947 Free article.

7

Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant.

Suzuki H, Akashi Y, Kato D, Takeuchi Y, Kiyasu Y, Terada N, Kurihara Y, Kuwahara M, Muramatsu S, Ueda A, Notake S, Nakamura K. Suzuki H, et al. Among authors: nakamura k. J Infect Chemother. 2023 Mar;29(3):257-262. doi: 10.1016/j.jiac.2022.11.006. Epub 2022 Nov 20. J Infect Chemother. 2023. PMID: 36417995 Free PMC article.

8

Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo.

Passariello M, Yoshioka A, Takahashi K, Hashimoto SI, Inoue T, Nakamura K, De Lorenzo C. Passariello M, et al. Among authors: nakamura k. J Exp Clin Cancer Res. 2022 Sep 7;41(1):269. doi: 10.1186/s13046-022-02474-3. J Exp Clin Cancer Res. 2022. PMID: 36071464 Free PMC article.

9

Impacts of dosing and drug withdrawal period on tacrolimus-based triple therapy in a non-human primate renal transplantation model.

Naganuma Y, Maeda M, Nakamura K, Fukahori H, Satake H, Murakami R, Hanaoka K, Higashi Y, Koyama H, Morokata T. Naganuma Y, et al. Among authors: nakamura k. Transpl Immunol. 2022 Dec;75:101704. doi: 10.1016/j.trim.2022.101704. Epub 2022 Aug 31. Transpl Immunol. 2022. PMID: 36057381 Free article.

10

Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb).

Maki S, Tanaka H, Takakura S, Nii M, Tanaka K, Ogura T, Kotera M, Nishimura Y, Tamaru S, Ushida T, Tanaka Y, Kikuchi N, Kinjo T, Kawamura H, Takano M, Nakamura K, Suga S, Kasai M, Yasui O, Nagao K, Maegawa Y, Kotani T, Endo M, Yasuhi I, Aoki S, Aoki Y, Yoshida Y, Nakata M, Sekizawa A, Ikeda T. Maki S, et al. Among authors: nakamura k. BMJ Open. 2022 Jun 14;12(6):e054925. doi: 10.1136/bmjopen-2021-054925. BMJ Open. 2022. PMID: 35701067 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

148 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year